12/05/07 - Theregen Completes Phase I Enrollment...
07/24/07: Theregen Launches Second Phase I Study
06/07/07: Paul Quadros is Theregen's new CEO
02/07/06: Theregen announces equity investment from Guidant Corporation to develop Anginera™ epicardial patch
01/23/06: Cell Therapy News - Human Cells Applied as Patch Improve Cardiac Function After Heart Attack, According to a Report in Tissue Engineering
01/17/06 - Theregen receives $1.5 million from Sanderling Ventures To Conduct Anginera Phase I Trial